Parkinsonism.
D000547:Amantadine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use; D026741:Physical Therapy Modalities
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010640:Phenothiazines; D004295:Dihydroxyphenylalanine; D000547:Amantadine